$ZEPP Income Statement | Understand Stock

$ZEPP

$2.43 -$0.11 (4.33%) Live

Financial Statements

In millions of CNY; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues (including US$92,046, US$11,002 and nil with related parties for the years ended December 31, 2023, 2024 and 2025, respectively)
Cost of revenues (including US$82,237, US$9,426 and nil resulting from related parties sales for the years ended December 31, 2023, 2024 and 2025, respectively)
Gross profit
Operating expenses
Selling and marketing
General and administrative
Research and development
Total operating expenses
Operating loss
Other income and expenses
Interest income
Interest expenses
Realized gain from investments
Gain from fair value change of long-term investments
Impairment loss from a long-term investment
Impairment loss from investments
Other (expenses)/income, net

Loss before income tax and loss from equity method investments
Income taxes benefits/(expenses)
Loss before income/(loss) from equity method investments
Income/(loss) from equity method investments
Net loss
Less: Net loss attributable to non-controlling interest
Net loss attributable to Zepp Health Corporation
Net loss attributable to ordinary shareholders of Zepp Health Corporation
Net loss per share attributable to ordinary shareholders of Zepp Health Corporation
Basic loss per ordinary share
Diluted loss per ordinary share
Weighted average number of shares used in computing net loss per share
Ordinary share - basic
Ordinary share - diluted

Comments